lundi 30 juin 2014

Combatting drug resistance for melanoma patients

A new way to identify possible therapeutic targets for patients with drug resistant melanoma has been developed by researchers. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.

Combatting drug resistance for melanoma patients

Aucun commentaire:

Enregistrer un commentaire